TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

10100	Companies
206857	Keywords
137019	Articles
109643	Press releases

Home
Companies
TRANSGENE

BRIEF

published on 05/14/2024 at 17:50, 1 year 10 months ago

Transgene annonce une mise à jour positive pour le premier trimestre 2024 et de futures étapes cliniques

Essais Cliniques Mise À Jour Financière Immunothérapie Anticancéreuse Transgene TG4050
BRIEF

published on 05/14/2024 at 17:50, 1 year 10 months ago

Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones

Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 1 year 10 months ago

Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2024
Point sur les activités et la situation financière de Transgene au premier trimestre 2024, avec des données prometteuses de Phase I pour TG4050 et des prévisions de nouvelles données cliniques pour TG4001, TG6050 et BT-001

Biotechnologie Santé Financière Immunothérapie Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 1 year 10 months ago

Transgene provides business and financial update for Q1 2024
Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024

Clinical Data Q1 2024 Financial Update Transgene TG4050

Accesswire

Published on 03/26/2026 at 23:00, 1 hour 27 minutes ago

FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 2 hours 22 minutes ago

BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 2 hours 27 minutes ago

Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 2 hours 27 minutes ago

Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 3 hours 27 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 20:48, 3 hours 39 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 5 hours 7 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:13, 5 hours 14 minutes ago

Director Declaration
Published on 03/26/2026 at 19:09, 5 hours 18 minutes ago

2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 5 hours 18 minutes ago

2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)

Les Echos

Published on 03/26/2026 at 18:17, 6 hours 10 minutes ago

Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 6 hours 10 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 6 hours 27 minutes ago

Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 6 hours 27 minutes ago

Calendrier financier 2026
Published on 03/26/2026 at 18:00, 6 hours 27 minutes ago

LABORATOIRES EUROMEDIS - Fin du contrat de liquidité

View all LES ECHOS COMFI WIRE